AEON Biopharma, Inc. Financial Flexibility Index
AEON Biopharma, Inc. financial flexibility index. AEON Biopharma, Inc. (AEON) has a Financial Flexibility Index of -0.09x as of September 2025. Free cash flow of $-2.60 Million (operating CF $-2.60 Million minus capex $0.00) represents 0% of total liabilities ($28.61 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of AEON Biopharma, Inc. (2019–2024)
Financial flexibility index of AEON Biopharma, Inc. from 2019 to 2024. Historical Financial Flexibility Index trend for AEON Biopharma, Inc. across 6 annual periods. Check AEON Biopharma, Inc. cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
AEON Biopharma, Inc. Financial Flexibility Index by Year (2019–2024)
AEON Biopharma, Inc. financial flexibility index by year from 2019 to 2024. Year-by-year free cash flow to debt coverage for AEON Biopharma, Inc.. For the full cash flow conversion analysis, see AEON Biopharma, Inc. operating cash flow efficiency.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.64x | $-20.29 Million | $-20.29 Million | $31.71 Million | ▼ -113.9% |
| 2023 | -0.30x | $-47.83 Million | $-47.83 Million | $159.89 Million | ▼ -138.4% |
| 2022 | -0.13x | $-35.28 Million | $-35.58 Million | $281.19 Million | ▼ -2.2% |
| 2021 | -0.12x | $-28.26 Million | $-28.43 Million | $230.26 Million | ▼ -196.5% |
| 2020 | -0.04x | $-9.29 Million | $-9.46 Million | $224.45 Million | ▲ +82.7% |
| 2019 | -0.24x | $-43.03 Million | $-44.73 Million | $180.22 Million | — |